Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Quest Diagnostics (NY: DGX )

152.93 -1.30 (-0.84%)
Official Closing Price Updated: 7:00 PM EDT, Sep 6, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Quest Diagnostics

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Benzinga's Top Ratings Upgrades, Downgrades For April 4, 2022
Upgrades 
Via Benzinga
Positive Drug Tests Among US Workers Higher Than In Last 20 Years; Does That Include Cannabis?
Which of these is correct? The number of cannabis consumers has increased or more people have stopped concealing their consumption as marijuana legalization spreads across the United States?  
Via Benzinga
Quest Diagnostics Secures CDC Contract To Support COVID-19 Research
Via Benzinga
The Daily Biotech Pulse: Novartis Prostate Cancer Drug Lands FDA Approval, Ligand Announces SPAC Deal To Spin Off Antibody Business, Lilly's Lung Cancer Therapy Hit With CRL
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Earnings Scheduled For February 3, 2022
Companies Reporting Before The Bell • Tuesday Morning (NASDAQ:TUEM) is likely to report earnings for its second quarter. 
Via Benzinga
Quest Diagnostics Incorporated (NYSE:DGX) Investor Notice: Investigation over Possible Securities Laws Violations
San Diego, CA -- (SBWIRE) -- 03/23/2022 -- Quest Diagnostics Incorporated was under investigation over potential securities laws violations in connection with certain financial statements. 
Via SBWire
7 Healthcare Stocks to Buy for the Long Term
When the markets go through the massive transitions they're seeing right now, it's a great time to add quality healthcare stocks. 
Via InvestorPlace
This Foreboding Sign Looms Over Quest Diagnostics's Chart
If history is any guide, there may be trouble ahead for shares of Quest Diagnostics (NYSE:DGX). A so-called "death cross" has formed on its chart and, not surprisingly, this... 
Via Benzinga
A Look Into Healthcare Sector Value Stocks
What is a Value Stock? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples... 
Via Benzinga
What 8 Analyst Ratings Have To Say About Quest Diagnostics
Analysts have provided the following ratings for Quest Diagnostics (NYSE:DGX) within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total... 
Via Benzinga
Development of Novel Innovative Diagnostic tests Generating Huge Revenue Opportunity for Global Blood Testing Market
Palm Beach, FL – February 16, 2022 – FinancialNewsMedia.com News Commentary – The global blood testing market has grown during the pandemic and is expected to continue to rise in the coming years.... 
Via FinancialNewsMedia
Exposures COVID-19
Quest Diagnostics Q4 Earnings, FY22 Reflects Lower Demand For COVID-19 Testing Services
Quest Diagnostics Incorporated (NYSE: DGX) posted a better-than-expected  
Via Benzinga
FORTUNE Magazine Names Quest Diagnostics One of 2022 "World's Most Admired Companies" For Eighth Consecutive Year
SOURCE: Quest Diagnostics 
Via 3BL Media
The Daily Biotech Pulse: Big Pharma Earnings Prove Lackluster, Mersana Inks $1B ADC R&D Deal, Syros Gets Orphan Drug Designation
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Recap: Quest Diagnostics Q4 Earnings
  Quest Diagnostics (NYSE:DGX) reported its Q4 earnings results on Thursday, February 3, 2022 at 06:45 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Walmart and Quest Diagnostics Empower People to Take Control of Their Healthcare Through New Consumer-Initiated Laboratory Testing Solution Powered by QuestDirect™ Through Walmart.com
SOURCE: Quest Diagnostics 
Via 3BL Media
Quest Diagnostics Receives Perfect Score on Human Rights Campaign Foundation's Corporate Equality Index for Sixth Consecutive Year
SOURCE: Quest Diagnostics 
Via 3BL Media
Benzinga's Top Ratings Upgrades, Downgrades For February 2, 2022
Upgrades Oppenheimer upgraded the previous rating for NovoCure Ltd (NASDAQ:NVCR) from Perform to Outperform. NovoCure earned $0.13 in the third quarter, compared to $0.09... 
Via Benzinga
Project HOPE Awarded Grant to Reduce Transmission of COVID-19 Variants in Long-term Care Facilities
SOURCE: Quest Diagnostics 
Via 3BL Media
Exposures COVID-19
7 Undervalued Stocks That Won’t Stay That Way for Long
With growing concerns about stability inducing significant fear, contrarians may have an opportunity with undervalued stocks. 
Via InvestorPlace
FeganScott Announces Investigation into Prenatal Testing Options Revealing Flawed Genetic Results
--News Direct-- 
Via News Direct
26 Firms Going Ex-Dividend Next Week, Including CVS Health, APA Corp. And Procter & Gamble
There are several well known large cap stocks going ex-dividend next week including 4 of our Top 100 Dividend Stocks. 
Via Talk Markets
Monday Is Your Last Chance To Buy Quest Diagnostics Before The Dividend Payout
Monday marks the last chance for investors to receive the next dividend payout from Quest Diagnostics. What's Happening (NYSE: 
Via Benzinga
Quest Diagnostics Inc Slammed After Earnings, Here’s Where It's Going
The next major support level for Quest Diagnostics Inc stock will be around the $140.00 level. This support area is where the stock broke out to the upside in early November 2021. 
Via Talk Markets
Quest Diagnostics Stock Falls As FY22 EPS Outlook Lags Consensus
Quest Diagnostics Inc (NYSE: DGX) expects Q4 sales of $2.74 billion, a decrease of 9% Y/Y, beating the consensus of $2.54 billion. The company noted preliminary Q4... 
Via Benzinga
Free COVID Tests: What Stocks Will Benefit?
The government hasn’t announced yet what company or companies it will be buying from, but there are several businesses involved in producing these kits. 
Via Talk Markets
QDEL Stock Alert: What Is Going on With Quidel Today?
The nearing holidays mean an increasing demand for Covid-19 testing kits. Leading provider Quidel is seeing QDEL stock rise as a result. 
Via InvestorPlace
Quest Diagnostics Earns Gold Status in American Heart Association's 2021 Workplace Health Achievement Index
SOURCE: Quest Diagnostics 
Via 3BL Media
Price Over Earnings Overview: Quest Diagnostics
In the current session, Quest Diagnostics Inc. (NYSE:DGX) is trading at $163.60, after a 0.21% gain. Over the past month, the stock increased by 10.55%, and in the past... 
Via Benzinga
Quest Announces Annual Sustainability Awards
SOURCE: Quest Diagnostics 
Via 3BL Media
Topics Emissions
Exposures COVID-19
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.